The size of the Middle East and Africa Autoimmune Diagnostics Market was worth USD 0.60 billion in 2022 and estimated to reach USD 0.70 billion by the end of 2027, growing at a CAGR of 3.108% between 2022 to 2027.
Autoimmune diseases are an active hyperimmune response against their own body tissues and cells. Due to mergers and acquisitions that provide an increasing opportunity in this region. The most common autoimmune diseases include rheumatoid arthritis, type 1 diabetes, and multiple sclerosis.
The Middle East & Africa market is driven by the increasing prevalence of autoimmune disorders improving healthcare infrastructure.
Cost issues and problems of skilled manpower are the factors that hinder the growth of the market.
This research report is on the Middle East and Africa Autoimmune diagnostics market has been segmented & sub-segmented into the following categories:
By Test Type:
By Disease Type:
By End User:
Companies like Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc are playing a notable role in the MEA autoimmune diagnostics market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org